PIP Breast Implants - HJA Guidance
Silicone Breast Implant Compensation
Peter
Todd, Solicitor, Hodge Jones & Allen
LLP
Tuesday 3rd January 2012
We have been contacted by a number of women
seeking legal advice regarding the possibility of recovering
compensation in relation to their silicone breast implants.
Thousands of British women have received
silicone breast implants manufactured by French manufacturer Poly
Implant Prosthese (“PIP”).
PIP has gone into liquidation following the
recall of their implants products by the French medical regulatory
authority (“AFSSAPS”). This raises serious questions as to whether
Claimants will be able to successfully recover compensation.
Investigations and tests by regulatory
authorities in the USA, France and UK have established a higher
than normal rupture rate of PIP prostheses, that some silicone used
was not of the approved standard, and a report in France of the
death of a woman implanted with PIP breast implants from Anaplastic
Large Cell Lymphoma (“ALCL”). ALCL is a rare form of cancer which
affects cells from the immune system.
The UK Regulator of medical devices is the
Medicines and Healthcare Products Regulatory Agency. The MHRA website
contains updates from the Agency on this problem.
The MHRA is advising patients to seek medical
advice from their implanting surgeon. The MHRA currently does not
advise routine revision surgery, although the French regulatory
agency has advised routine revision surgery.
Due to the liquidation of PIP, it is unlikely
it will be cost effective for proceedings to be taken against the
manufacturer. There does not presently seem to be a product
liability insurer willing to accept a liability to settle claims
against PIP.
There is a possibility Claimants may have
claims against their treating doctor if there was medical
negligence in the treatment. However this is likely to require a
special circumstance in an individual case, and is unlikely to
apply to many people. The clinical negligence team at HJA will
however assist any client who wants that issue fully investigated
although it is likely the costs of the investigation will have to
be paid privately as legal aid is not likely to be available.
Some household insurance policies contain
“reverse indemnity” cover. This is insurance against the risk that
you may not be able to recover compensation from someone because
(for example) they are uninsured or insolvent. However the
exclusions to most standard policies exclude cover where the claim
arose from a business activity – such as product liability. It is
worth checking the detail of your insurance cover to see whether
your policy might cover you. Strict time limits may apply.
We are investigating in some cases the
possibility of a claim against the clinic which contracted with the
patient for the supply of the implant. The contract is subject to
the Sale of Goods & Services Act 1982 which provides that there
is an implied term that the implants will be of “satisfactory
quality”. This means “if they meet the standard that a reasonable
person would regard as satisfactory, taking account of any
description of the goods, the price (if relevant) and all the other
relevant circumstances.” A court will award compensation for breach
of this implied term which will put the patient back into the
position they would have been in had the contract been properly
performed; in most cases this will cover pain and suffering of a
revision operation and the treatment and consultation involved and
consequential loss.
Given the current situation it is likely that
pressure will mount on the UK government to establish a
compensation scheme to cover medical expenses and other losses. We
suggest you lobby your MP on the issue.